We can orally deliver any biologics to the colon, ranging from small peptides to mAbs.

***

Plantibodies’ Unique Advantages:

A novel single step process of combining biologics manufacturing & encapsulation for oral administration and colonic release

Final formulation contains only naturally occurring polymers, which forms a protective shell around the active biologics (no additional chemical coating or nanoparticle required).

The final product prevents aggregation and precipitation of biologics, for increased activity.

These advantages can be extended to a range of small peptides (<20kDa) to macromolecules (IgG, IgA - 250kDa) to target the GI.

***

Plantibodies is interested in expanding and diversifying its pipeline via
feasibility studies, industrial partnerships and research collaborations, co-development, in & out licensing.